103 related articles for article (PubMed ID: 18541996)
1. The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update.
Lyssenko V
Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):385-92. PubMed ID: 18541996
[TBL] [Abstract][Full Text] [Related]
2. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
[TBL] [Abstract][Full Text] [Related]
4. Prime suspect: the TCF7L2 gene and type 2 diabetes risk.
Hattersley AT
J Clin Invest; 2007 Aug; 117(8):2077-9. PubMed ID: 17671643
[TBL] [Abstract][Full Text] [Related]
5. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
Vahl T; D'Alessio D
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
[TBL] [Abstract][Full Text] [Related]
6. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
Jin T; Liu L
Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
[TBL] [Abstract][Full Text] [Related]
7. Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men.
Dahlgren A; Zethelius B; Jensevik K; Syvänen AC; Berne C
Diabetologia; 2007 Sep; 50(9):1852. PubMed ID: 17618413
[TBL] [Abstract][Full Text] [Related]
8. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
Wang J; Kuusisto J; Vänttinen M; Kuulasmaa T; Lindström J; Tuomilehto J; Uusitupa M; Laakso M
Diabetologia; 2007 Jun; 50(6):1192-200. PubMed ID: 17437080
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function.
Gloyn AL; Braun M; Rorsman P
Diabetes; 2009 Apr; 58(4):800-2. PubMed ID: 19336690
[No Abstract] [Full Text] [Related]
10. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells.
Loder MK; da Silva Xavier G; McDonald A; Rutter GA
Biochem Soc Trans; 2008 Jun; 36(Pt 3):357-9. PubMed ID: 18481957
[TBL] [Abstract][Full Text] [Related]
11. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population.
Horikoshi M; Hara K; Ito C; Nagai R; Froguel P; Kadowaki T
Diabetologia; 2007 Apr; 50(4):747-51. PubMed ID: 17245589
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling in pancreatic islets.
Liu Z; Habener JF
Adv Exp Med Biol; 2010; 654():391-419. PubMed ID: 20217507
[TBL] [Abstract][Full Text] [Related]
13. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.
Schäfer SA; Tschritter O; Machicao F; Thamer C; Stefan N; Gallwitz B; Holst JJ; Dekker JM; 't Hart LM; Nijpels G; van Haeften TW; Häring HU; Fritsche A
Diabetologia; 2007 Dec; 50(12):2443-50. PubMed ID: 17661009
[TBL] [Abstract][Full Text] [Related]
14. Role of Wnt signaling in the development of type 2 diabetes.
Bordonaro M
Vitam Horm; 2009; 80():563-81. PubMed ID: 19251050
[TBL] [Abstract][Full Text] [Related]
15. Risk loci for type 2 diabetes - quo vadis?
Weijers RN
Clin Chem Lab Med; 2009; 47(4):383-6. PubMed ID: 19203201
[TBL] [Abstract][Full Text] [Related]
16. Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes.
Müssig K; Staiger H; Machicao F; Stancáková A; Kuusisto J; Laakso M; Thamer C; Machann J; Schick F; Claussen CD; Stefan N; Fritsche A; Häring HU
J Clin Endocrinol Metab; 2009 Apr; 94(4):1353-60. PubMed ID: 19141580
[TBL] [Abstract][Full Text] [Related]
17. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells.
da Silva Xavier G; Loder MK; McDonald A; Tarasov AI; Carzaniga R; Kronenberger K; Barg S; Rutter GA
Diabetes; 2009 Apr; 58(4):894-905. PubMed ID: 19168596
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets.
Shu L; Sauter NS; Schulthess FT; Matveyenko AV; Oberholzer J; Maedler K
Diabetes; 2008 Mar; 57(3):645-53. PubMed ID: 18071026
[TBL] [Abstract][Full Text] [Related]
19. Variation in the CDKAL1 gene is associated with the titer of antibodies to GAD.
Haupt A; Guthoff M; Gallwitz B; Haring HU; Fritsche A
Diabetes Care; 2008 Sep; 31(9):e66. PubMed ID: 18753662
[No Abstract] [Full Text] [Related]
20. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
Florez JC; Jablonski KA; Bayley N; Pollin TI; de Bakker PI; Shuldiner AR; Knowler WC; Nathan DM; Altshuler D;
N Engl J Med; 2006 Jul; 355(3):241-50. PubMed ID: 16855264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
